CAS 2455427-91-3

AZD0780

CAS : 2455427-91-3

AZD0780

Degré de pureté : ≥95%

Masse moléculaire : 414.41g/mol

Ref: 54-BUP09434

AZD0780

CAS : 2455427-91-3

AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.Cost-effective and quality-assured.

Formule : C₂₀H₂₀F₂N₆O₂

Degré de pureté : 97.61% - 99.74%

Couleur et forme : Soild

Masse moléculaire : 414.41

Ref: TM-T64362